On Wednesday, Gossamer Bio Inc (GOSS) stock saw a decline, ending the day at $0.82 which represents a decrease of $-0.03 or -3.53% from the prior close of $0.85. The stock opened at $0.86 and touched ...
A downtrend has been apparent in Gossamer Bio (GOSS) lately with too much selling pressure. The stock has declined 15.9% over the past four weeks. However, given the fact that it is now in oversold ...
Gossamer Bio (GOSS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 11. Analyst Joseph Schwartz from Leerink Partners reiterated a Buy rating on ...
Gossamer Bio, Inc. ( NASDAQ:GOSS) shareholders will have a reason to smile today, with the analysts making substantial upgrades to next year's statutory forecasts. The consensus estimated revenue ...
In a report released today, Andreas Argyrides from Oppenheimer maintained a Buy rating on Gossamer Bio (GOSS – Research Report), with a price target of $9.00. The company’s shares closed yesterday at ...
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary ...
Anti-abortion advocates say there is still work to be done to further restrict access to abortion when Republican Donald Trump returns to the White House next year. They point to the federal guidance ...